Europe Migraine Drugs Market Size & Outlook, 2024-2030

The migraine drugs market in Europe is expected to reach a projected revenue of US$ 3,192.4 million by 2030. A compound annual growth rate of 9.3% is expected of Europe migraine drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$1,772.2
Forecast, 2030 (US$M)
$3,192.4
CAGR, 2025 - 2030
9.3%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe migraine drugs market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe migraine drugs market highlights

  • The Europe migraine drugs market generated a revenue of USD 1,772.2 million in 2024.
  • The market is expected to grow at a CAGR of 10.3% from 2025 to 2030.
  • In terms of segment, otc was the largest revenue generating product in 2024.
  • OTC is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.


Europe data book summary

Market revenue in 2024USD 1,772.2 million
Market revenue in 2030USD 3,192.4 million
Growth rate10.3% (CAGR from 2025 to 2030)
Largest segmentOtc
Fastest growing segmentOTC
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC, Prescription
Key market players worldwideGlaxoSmithKline, Pfizer Inc, AbbVie Inc, Amgen Inc, Eli Lilly and Co, Teva Pharmaceutical Industries Ltd, Biohaven Ltd, Johnson & Johnson, Bausch Health Companies Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 26.0% of the global migraine drugs market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 6,610.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Migraine Drugs Market Companies

Name Profile # Employees HQ Website

Europe migraine drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to migraine drugs market will help companies and investors design strategic landscapes.


Otc was the largest segment with a revenue share of 62.37% in 2024. Horizon Databook has segmented the Europe migraine drugs market based on otc, prescription covering the revenue growth of each sub-segment from 2018 to 2030.


Europe market was identified as a lucrative region in this industry. The growth of the market in the region can be attributed to a significant population affected by migraines, contributing to a substantial market size for these drugs. 

Reasons to subscribe to Europe migraine drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe migraine drugs market databook

  • Our clientele includes a mix of migraine drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe migraine drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Europe migraine drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe migraine drugs market size, by country, 2018-2030 (US$M)

Europe Migraine Drugs Market Outlook Share, 2024 & 2030 (US$M)

Europe migraine drugs market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online